Order Article Reprints

Shatalov PA, Bukaeva AA, Veselovsky EM, Traspov AA, Bagdasarova DV, Leukhina IA, Shinkarkina AP, Raygorodskaya MP, Murzaeva AV, Mechenici YA, et al. Neoantigen-Driven Immunotherapy in Triple-Negative Breast Cancer: Emerging Strategies and Clinical Potential. Biomedicines. 2025; 13(9):2213. https://doi.org/10.3390/biomedicines13092213

Shatalov, Peter A., Anna A. Bukaeva, Egor M. Veselovsky, Alexey A. Traspov, Daria V. Bagdasarova, Irina A. Leukhina, Anna P. Shinkarkina, Maria P. Raygorodskaya, Alena V. Murzaeva, Yulia A. Mechenici, and et al. 2025. "Neoantigen-Driven Immunotherapy in Triple-Negative Breast Cancer: Emerging Strategies and Clinical Potential" Biomedicines 13, no. 9: 2213. https://doi.org/10.3390/biomedicines13092213

Shatalov, P. A., Bukaeva, A. A., Veselovsky, E. M., Traspov, A. A., Bagdasarova, D. V., Leukhina, I. A., Shinkarkina, A. P., Raygorodskaya, M. P., Murzaeva, A. V., Mechenici, Y. A., Revkova, M. A., Kaprin, A. D., & Shegai, P. V. (2025). Neoantigen-Driven Immunotherapy in Triple-Negative Breast Cancer: Emerging Strategies and Clinical Potential. Biomedicines, 13(9), 2213. https://doi.org/10.3390/biomedicines13092213